Early research (Phase 1)Ended earlyNCT01918761
What this trial is testing
Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)
Who this might be right for
Non Small Cell Lung Cancer
Central European Cooperative Oncology Group 5